A Review on Bacterial Resistance to Carbapenems: epidemiology, Detection and Treatment Options

References

• Antimicrobial Resistance in Developing Countries.SosaA de J, ByarugabaDK, AmabileC, HsuehPR, KariukiS, OkekeIN ( Eds). Springer, NY, USA (2010).
   Google Scholar
• SugdenR , KellyR , DaviesS. Combatting antimicrobial resistance globally. Nat. Microbiol.1(10), 16187 (2016).
   PubMed Web of Science ®Google Scholar
• WHO. Global antimicrobial resistance surveillance system (GLASS) report: early implementation 2017–2018 (2018). www.apps.who.int/iris/bitstream/handle/10665/279656/9789241515061-eng.pdf?ua=1
   Google Scholar
• HolmesAH , MooreLSP , SundsfjordAet al.Understanding the mechanisms and drivers of antimicrobial resistance. Lancet387(10014), 176–187 (2016).
   PubMed Web of Science ®Google Scholar
• TenoverFC. Mechanisms of antimicrobial resistance in bacteria. Am. J. Infect. Control34(5), S3–S10 (2006).
   PubMed Web of Science ®Google Scholar
• WalshC. Molecular mechanisms that confer antibacterial drug resistance. Nature406(6797), 775–781 (2000).
   PubMed Web of Science ®Google Scholar
• BruntonLL , KnollmannBC , Hilal-DandanR. Goodman & Gilman's the pharmacological basis of therapeutics (13th Edition). ShanahanJF, LebowitzH ( Ed.). McGraw Hill Medical, NY, USA (2018).
   Google Scholar
• WalshC. Antibiotics: actions, origins, resistance. ASM Press, Washington DC, USA (2003).
   Google Scholar
• El-GamalMI , BrahimI , HishamN , AladdinR , MohammedH , BahaaeldinA. Recent updates of carbapenem antibiotics. Eur. J. Med. Chem.131, 185–195 (2017).
   PubMed Web of Science ®Google Scholar
• MeletisG. Carbapenem resistance: overview of the problem and future perspectives. Ther. Adv. Infect. Dis.3(1), 15–21 (2016).
   PubMed Web of Science ®Google Scholar
• BirnbaumJ , KahanFM , KroppH , MacdonaldJS. Carbapenems, a new class of beta-lactam antibiotics: discovery and development of imipenem/cilastatin. Am. J. Med.78(6), 3–21 (1985).
   PubMed Web of Science ®Google Scholar
• KahanJS , KahanFM , GoegelmanRet al.Thienamycin, a new beta-lactam antibiotic. I. Discovery, taxonomy, isolation and physical properties. J. Antibiot. (Tokyo)32(1), 1–12 (1979).
   PubMed Web of Science ®Google Scholar
• LeeY , BradleyN. Overview and insights into Carbapenem allergy. Pharmacy7(3), 110–116 (2019).
   Web of Science ®Google Scholar
• FoyeWO , LemkeTL , WilliamsDA. Foye's Principles of Medicinal Chemistry (7th Edition). Wolters Kluwer Health/Lippincott Williams & Wilkins, PA, USA (2013).
   Google Scholar
• GraysonML. Kucers' the Use of Antibiotics: a Clinical Review of Antibacterial, Antifungal, Antiparasitic and Antiviral Drugs (6th Edition). CRC Press, FL, USA (2012).
   Google Scholar
• BuckleyMM , BrogdenRN , BarradellLB , GoaKL. Imipenem/Cilastatin. Drugs44(3), 408–444 (1992).
   PubMed Web of Science ®Google Scholar
• FischerJ , GanellinCR. Analogue-based drug discovery (6th Edition). Wiley-VCH, Weinheim, Germany (2006).
   Google Scholar
• NordmannP , DortetL , PoirelL. Carbapenem resistance in Enterobacteriaceae: here is the storm! Trends Mol. Med.18(5), 263–272 (2012).
   PubMed Web of Science ®Google Scholar
• EllappanK , BelgodeNarasimha H , KumarS. Coexistence of multidrug resistance mechanisms and virulence genes in carbapenem-resistant Pseudomonas aeruginosa strains from a tertiary care hospital in South India. J. Glob. Antimicrob. Resist.12, 37–43 (2018).
   PubMed Web of Science ®Google Scholar
• ElshamyA , AboshanabK , YassienM , HassounaN. Prevalence of carbapenem resistance among multidrug-resistant Gram-negative uropathogens. Arch. Pharm. Sci. Ain Shams Univ.2(2), 70–77 (2018).
   Google Scholar
• ZhanelGG , WiebeR , DilayLet al.Comparative review of the carbapenems. Drugs67(7), 1027–1052 (2007).
   PubMed Web of Science ®Google Scholar
• SolomkinJS , MazuskiJE , BradleyJSet al.Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America. Clin. Infect. Dis.50(2), 133–164 (2010).
   PubMed Web of Science ®Google Scholar
• Papp-WallaceKM , EndimianiA , TaracilaMA , BonomoRA. Carbapenems: past, present, and future. Antimicrob. Agents Chemother.55(11), 4943–4960 (2011).
   PubMed Web of Science ®Google Scholar
• FisherJF , MerouehSO , MobasheryS. Bacterial resistance to β-Lactam antibiotics: compelling opportunism, compelling opportunity. Chem. Rev.105(2), 395–424 (2005).
   PubMed Web of Science ®Google Scholar
• KapoorG , SaigalS , ElongavanA. Action and resistance mechanisms of antibiotics: a guide for clinicians. J. Anaesthesiol. Clin. Pharmacol.33(3), 300–305 (2017).
   PubMedGoogle Scholar
• HeijenoortJv. Formation of the glycan chains in the synthesis of bacterial peptidoglycan. Glycobiology11, 25R–36R (2001).
   PubMed Web of Science ®Google Scholar
• ScholarEM , PrattWB. The Antimicrobial Drugs (2nd Edition). Oxford University Press, NY, USA (2000).
   Google Scholar
• NordmannP , NaasT , PoirelL. Global spread of carbapenemase-producing Enterobacteriaceae. Emerg. Infect. Dis.17(10), 1791–1798 (2011).
   PubMed Web of Science ®Google Scholar
• BlairJMA , WebberMA , BaylayAJ , OgboluDO , PiddockLJV. Molecular mechanisms of antibiotic resistance. Nat. Rev. Microbiol.13(1), 42–51 (2015).
   PubMed Web of Science ®Google Scholar
• TzouvelekisLS , MarkogiannakisA , PsichogiouM , TassiosPT , DaikosGL. Carbapenemases in Klebsiella pneumoniae and other Enterobacteriaceae: an evolving crisis of global dimensions. Clin. Microbiol. Rev.25(4), 682–707 (2012).
   PubMed Web of Science ®Google Scholar
• Durante-MangoniE , AndiniR , ZampinoR. Management of carbapenem-resistant Enterobacteriaceae infections. Clin. Microbiol. Infect.25(8), 943–950 (2019).
   PubMed Web of Science ®Google Scholar
• YangD , GuoY , ZhangZ. Combined porin loss and extended spectrum β-lactamase production is associated with an increasing imipenem minimal inhibitory concentration in clinical Klebsiella pneumoniae strains. Curr. Microbiol.58(4), 366–370 (2009).
   PubMed Web of Science ®Google Scholar
• LoganLK , WeinsteinRA. The epidemiology of carbapenem-resistant Enterobacteriaceae: the impact and evolution of a global menace. J. Infect. Dis.215(Suppl. 1), S28–S36 (2017).
   PubMedGoogle Scholar
• LittleML , QinX , ZerrDM , WeissmanSJ. Molecular diversity in mechanisms of carbapenem resistance in paediatric Enterobacteriaceae. Int. J. Antimicrob. Agents39(1), 52–57 (2012).
   PubMed Web of Science ®Google Scholar
• DoumithM , EllingtonMJ , LivermoreDM , WoodfordN. Molecular mechanisms disrupting porin expression in ertapenem-resistant Klebsiella and Enterobacter spp. clinical isolates from the UK. J. Antimicrob. Chemother.63(4), 659–667 (2009).
   PubMed Web of Science ®Google Scholar
• FarraA , IslamS , StrålforsA , SörbergM , WretlindB. Role of outer membrane protein OprD and penicillin-binding proteins in resistance of Pseudomonas aeruginosa to imipenem and meropenem. Int. J. Antimicrob. Agents31(5), 427–433 (2008).
   PubMed Web of Science ®Google Scholar
• Garcia-FernandezA , MiriagouV , PapagiannitsisCCet al.An ertapenem-resistant extended-spectrum-β-lactamase-producing Klebsiella pneumoniae clone carries a novel OmpK36 porin variant. Antimicrob. Agents Chemother.54(10), 4178–4184 (2010).
   PubMed Web of Science ®Google Scholar
• LomovskayaO , ZgurskayaHI , TotrovM , WatkinsWJ. Waltzing transporters and “the dance macabre” between humans and bacteria. Nat. Rev. Drug Discov.6(1), 56–65 (2007).
   PubMed Web of Science ®Google Scholar
• KingDT , SobhanifarS , StrynadkaNCJ. The mechanisms of resistance to β-lactam antibiotics. In: Handbook of Antimicrobial Resistance.BerghuisA, MatlashewskiG, WainbergMA, SheppardD ( Eds). Springer New York, NY, USA, 177–201 (2017).
   Google Scholar
• MeletisG , ExindariM , VavatsiN , SofianouD , DizaE. Mechanisms responsible for the emergence of carbapenem resistance in Pseudomonas aeruginosa. Hippokratia16(4), 303–307 (2012).
   PubMed Web of Science ®Google Scholar
• JacobyGA , Munoz-PriceLS. The new β-lactamases. N. Engl. J. Med.352(4), 380–391 (2005).
   PubMed Web of Science ®Google Scholar
• DoughertyTJ , PucciMJ. Antibiotic discovery and development. Springer Science and Business Media, NY, USA (2012).
   Google Scholar
• PatelG , BonomoRA. “Stormy waters ahead”: global emergence of carbapenemases. Front. Microbiol.4, 48–64 (2013).
   PubMed Web of Science ®Google Scholar
• DjahmiN , Dunyach-RemyC , PantelA , DekhilM , SottoA , LavigneJ-P. Epidemiology of carbapenemase-producing Enterobacteriaceae and Acinetobacter baumannii in mediterranean countries. BioMed Res. Int.2014, 1–11 (2014).
   Web of Science ®Google Scholar
• NordmannP , CuzonG , NaasT. The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria. Lancet Infect. Dis.9(4), 228–236 (2009).
   PubMed Web of Science ®Google Scholar
• PfeiferY , CullikA , WitteW. Resistance to cephalosporins and carbapenems in Gram-negative bacterial pathogens. Int. J. Med. Microbiol.300(6), 371–379 (2010).
   PubMed Web of Science ®Google Scholar
• CuzonG , NaasT , TruongHet al.Worldwide diversity of Klebsiella pneumoniae that produce beta-lactamase blaKPC-2 gene. Emerg. Infect. Dis.16(9), 1349–1356 (2010).
   PubMed Web of Science ®Google Scholar
• MiltgenG , BonninRA , AvrilCet al.Outbreak of IMI-1 carbapenemase-producing colistin-resistant Enterobacter cloacae on the French island of Mayotte (Indian Ocean). Int. J. Antimicrob. Agents52(3), 416–420 (2018).
   PubMed Web of Science ®Google Scholar
• TakanoC , SekiM , KimDWet al.Development of a novel loop-mediated isothermal amplification method to detect guiana extended-spectrum (GES) β-lactamase genes in Pseudomonas aeruginosa. Front. Microbiol.10, 25–31 (2019).
   PubMed Web of Science ®Google Scholar
• QueenanAM , BushK. Carbapenemases: the versatile β-lactamases. Clin. Microbiol. Rev.20(3), 440–458 (2007).
   PubMed Web of Science ®Google Scholar
• SabathLD , AbrahamEP. Zinc as a Cofactor for Cephalosporinase from Bacillus cereus 569. Biochem. J.98(1), 11C–13C (1966).
   PubMed Web of Science ®Google Scholar
• WatanabeM , IyobeS , InoueM , MitsuhashiS. Transferable imipenem resistance in Pseudomonas aeruginosa. Antimicrob. Agents Chemother.35(1), 147–151 (1991).
   PubMed Web of Science ®Google Scholar
• WalshTR , TolemanMA , PoirelL , NordmannP. Metallo-β -lactamases: the quiet before the storm?Clin. Microbiol. Rev.18(2), 306–325 (2005).
   PubMed Web of Science ®Google Scholar
• WalshTR. Emerging carbapenemases: a global perspective. Int. J. Antimicrob. Agents36, S8–S14 (2010).
   PubMed Web of Science ®Google Scholar
• YongD , TolemanMA , GiskeCGet al.Characterization of a new metallo-β-lactamase gene, blaNDM-1. and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence Type 14 from India. Antimicrob. Agents Chemother.53(12), 5046–5054 (2009).
   PubMed Web of Science ®Google Scholar
• DoiY , PatersonD. Carbapenemase-producing Enterobacteriaceae. Semin. Respir. Crit. Care Med.36(01), 074–084 (2015).
   PubMedGoogle Scholar
• NordmannP , PoirelL , WalshTR , LivermoreDM. The emerging NDM carbapenemases. Trends Microbiol.19(12), 588–595 (2011).
   PubMed Web of Science ®Google Scholar
• RieberH , FrontzekA , PfeiferY. Emergence of metallo-β-lactamase GIM-1 in a clinical isolate of Serratia marcescens. Antimicrob. Agents Chemother.56(9), 4945–4947 (2012).
   PubMed Web of Science ®Google Scholar
• HongDJ , BaeIK , JangI-H , JeongSH , KangH-K , LeeK. Epidemiology and characteristics of metallo-β-lactamase-producing Pseudomonas aeruginosa. Infect. Chemother.47(2), 81 (2015).
   PubMed Web of Science ®Google Scholar
• MajiduddinFK , MateronIC , PalzkillTG. Molecular analysis of beta-lactamase structure and function. Int. J. Med. Microbiol.292(2), 127–137 (2002).
   PubMed Web of Science ®Google Scholar
• DaleJW , GodwinD , MossakowskaD , StephensonP , WallS. Sequence of the OXA2 β-lactamase: comparison with other penicillin-reactive enzymes. FEBS Lett.191(1), 39–44 (1985).
   PubMed Web of Science ®Google Scholar
• PoirelL , PotronA , NordmannP. OXA-48-like carbapenemases: the phantom menace. J. Antimicrob. Chemother.67(7), 1597–1606 (2012).
   PubMed Web of Science ®Google Scholar
• YigitH , QueenanAM , AndersonGJet al.Novel carbapenem-hydrolyzing β-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae. Antimicrob. Agents Chemother.45(4), 1151–1161 (2001).
   PubMed Web of Science ®Google Scholar
• YigitH , QueenanAM , AndersonGJet al.Novel carbapenem-hydrolyzing β-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae. Antimicrob. Agents Chemother.52(2), 809–809 (2008).
   Web of Science ®Google Scholar
• KitchelB , RasheedJK , PatelJBet al.Molecular epidemiology of KPC-producing Klebsiella pneumoniae isolates in the United States: clonal expansion of multilocus sequence Type 258. Antimicrob. Agents Chemother.53(8), 3365–3370 (2009).
   PubMed Web of Science ®Google Scholar
• MaltezouHC , GiakkoupiP , MaragosAet al.Outbreak of infections due to KPC-2-producing Klebsiella pneumoniae in a hospital in Crete (Greece). J. Infect.58(3), 213–219 (2009).
   PubMed Web of Science ®Google Scholar
• VillegasMV , LolansK , CorreaAet al.First identification of Pseudomonas aeruginosa isolates producing a KPC-Type carbapenem-hydrolyzing β-lactamase. Antimicrob. Agents Chemother.51(4), 1553–1555 (2007).
   PubMed Web of Science ®Google Scholar
• AgodiA , VoulgariE , BarchittaMet al.Containment of an outbreak of KPC-3-producing Klebsiella pneumoniae in Italy. J. Clin. Microbiol.49(11), 3986–3989 (2011).
   PubMed Web of Science ®Google Scholar
• Gomez-GilMR , Pano-PardoJR , Romero-GomezMPet al.Detection of KPC-2-producing Citrobacter freundii isolates in Spain. J. Antimicrob. Chemother.65(12), 2695–2697 (2010).
   PubMed Web of Science ®Google Scholar
• SenchynaF , GaurRL , SandlundJet al.Diversity of resistance mechanisms in carbapenem-resistant Enterobacteriaceae at a healthcare system in Northern California, from 2013 to 2016. Diagn. Microbiol. Infect. Dis.93(3), 250–257 (2019).
   PubMed Web of Science ®Google Scholar
• CastanheiraM , DeshpandeLM , MathaiD , BellJM , JonesRN , MendesRE. Early dissemination of NDM-1- and OXA-181-producing Enterobacteriaceae in Indian hospitals: report from the SENTRY Antimicrobial Surveillance Program, 2006–2007. Antimicrob. Agents Chemother.55(3), 1274–1278 (2011).
   PubMed Web of Science ®Google Scholar
• WalshTR , WeeksJ , LivermoreDM , TolemanMA. Dissemination of NDM-1 positive bacteria in the New Delhi environment and its implications for human health: an environmental point prevalence study. Lancet Infect. Dis.11(5), 355–362 (2011).
   PubMed Web of Science ®Google Scholar
• AungMS , SanN , MawWWet al.Prevalence of extended-spectrum Beta-lactamase and carbapenemase genes in clinical isolates of Escherichia coli in Myanmar: Dominance of blaNDM-5 and Emergence of blaOXA-181. Microb. Drug Resist.24(9), 1333–1344 (2018).
   PubMed Web of Science ®Google Scholar
• JafariZ , HaratiAA , HaeiliMet al.Molecular epidemiology and drug resistance pattern of carbapenem-resistant Klebsiella pneumoniae isolates from Iran. Microb. Drug Resist.25(3), 336–343 (2019).
   PubMed Web of Science ®Google Scholar
• MouftahSF , PálT , DarwishDet al.Epidemic IncX3 plasmids spreading carbapenemase genes in the United Arab Emirates and worldwide. Infect. Drug Resist.12, 1729–1742 (2019).
   PubMed Web of Science ®Google Scholar
• PoirelL , HeritierC , TolunV , NordmannP. Emergence of oxacillinase-mediated resistance to imipenem in Klebsiella pneumoniae. Antimicrob. Agents Chemother.48(1), 15–22 (2004).
   PubMed Web of Science ®Google Scholar
• CarrerA , PoirelL , EraksoyH , CagatayAA , BadurS , NordmannP. Spread of OXA-48-positive carbapenem-resistant Klebsiella pneumoniae isolates in Istanbul, Turkey. Antimicrob. Agents Chemother.52(8), 2950–2954 (2008).
   PubMed Web of Science ®Google Scholar
• CuzonG , OuanichJ , GondretR , NaasT , NordmannP. Outbreak of OXA-48-positive carbapenem-resistant Klebsiella pneumoniae isolates in France. Antimicrob. Agents Chemother.55(5), 2420–2423 (2011).
   PubMed Web of Science ®Google Scholar
• GlupczynskiY , HuangT-D , BouchahroufWet al.Rapid emergence and spread of OXA-48-producing carbapenem-resistant Enterobacteriaceae isolates in Belgian hospitals. Int. J. Antimicrob. Agents39(2), 168–172 (2012).
   PubMed Web of Science ®Google Scholar
• MoquetO , BouchiatC , KinanaAet al.Class D OXA-48 carbapenemase in multidrug-resistant Enterobacteria, Senegal. Emerg. Infect. Dis.17(1), 143–144 (2011).
   PubMed Web of Science ®Google Scholar
• MatarGM , DandacheI , CarrërAet al.Spread of OXA-48-mediated resistance to carbapenems in Lebanese Klebsiella pneumoniae and Escherichia coli that produce extended spectrum β-lactamase. Ann. Trop. Med. Parasitol.104(3), 271–274 (2010).
   PubMed Web of Science ®Google Scholar
• LahlaouiH , PoirelL , BarguellilF , MoussaMB , NordmannP. Carbapenem-hydrolyzing class D β-lactamase OXA-48 in Klebsiella pneumoniae isolates from Tunisia. Eur. J. Clin. Microbiol. Infect. Dis.31(6), 937–939 (2012).
   PubMed Web of Science ®Google Scholar
• KamelNA , El-tayebWN , El-AnsaryMR , MansourMT , AboshanabKM. Phenotypic screening and molecular characterization of carbapenemase-producing Gram-negative bacilli recovered from febrile neutropenic pediatric cancer patients in Egypt. PLoS ONE13(8), e0202119 (2018).
   PubMed Web of Science ®Google Scholar
• CorreaA , delC , ampoR , Escandón-VargasKet al.Distinct genetic diversity of carbapenem-resistant Acinetobacter baumannii from Colombian hospitals. Microb. Drug Resist.24(1), 48–54 (2018).
   PubMed Web of Science ®Google Scholar
• MorrillHJ , PogueJM , KayeKS , LaPlanteKL. Treatment options for carbapenem-resistant Enterobacteriaceae infections. Open Forum Infect. Dis.2(2), ofv050 (2015).
   PubMed Web of Science ®Google Scholar
• GautierG , GuillardT , PodacB , BercotB , Vernet-GarnierV , de ChampsC. Detection of different classes of carbapenemases: adaptation and assessment of a phenotypic method applied to Enterobacteriaceae, Pseudomonas aeruginosa and Acinetobacter baumannii, and proposal of a new algorithm. J. Microbiol. Methods147, 26–35 (2018).
   PubMed Web of Science ®Google Scholar
• WeinsteinMP. Performance Standards for Antimicrobial Susceptibility Testing. CLSI supplement M100 (28th Edition). Clinical and Laboratory Standards Institute, PA, USA (2018).
   Google Scholar
• SeahC , LowDE , PatelSN , MelanoRG. Comparative evaluation of a chromogenic Agar medium, the Modified Hodge test, and a battery of Meropenem-inhibitor discs for detection of carbapenemase activity in Enterobacteriaceae. J. Clin. Microbiol.49(5), 1965–1969 (2011).
   PubMed Web of Science ®Google Scholar
• PatelJB. Performance standards for antimicrobial susceptibility testing. CLSI supplement M100 (27th Edition).Clinical and Laboratory Standards Institute, PA, USA (2017).
   Google Scholar
• SegawaT , MatsuiM , SuzukiMet al.Utilizing the Carba NP test as an indicator of expression level of carbapenemase genes in Enterobacteriaceae. J. Microbiol. Methods133, 35–39 (2017).
   PubMed Web of Science ®Google Scholar
• PoirelL , NordmannP. Rapidec carba NP test for rapid detection of carbapenemase producers. J. Clin. Microbiol.53(9), 3003–3008 (2015).
   PubMed Web of Science ®Google Scholar
• van AlmsickV , GhebremedhinB , PfennigwerthN , Ahmad-NejadP. Rapid detection of carbapenemase-producing Acinetobacter baumannii and carbapenem-resistant Enterobacteriaceae using a bioluminescence-based phenotypic method. J. Microbiol. Methods147, 20–25 (2018).
   PubMed Web of Science ®Google Scholar
• WarehamDW , PheeLM , AbdulMomin MHF. Direct detection of carbapenem resistance determinants in clinical specimens using immunochromatographic lateral flow devices. J. Antimicrob. Chemother.73(7), 1997–1998 (2018).
   PubMed Web of Science ®Google Scholar
• GlupczynskiY , EvrardS , OteIet al.Evaluation of two new commercial immunochromatographic assays for the rapid detection of OXA-48 and KPC carbapenemases from cultured bacteria. J. Antimicrob. Chemother.71(5), 1217–1222 (2016).
   PubMed Web of Science ®Google Scholar
• NeonakisIK , SpandidosDA. Detection of carbapenemase producers by matrix-assisted laser desorption-ionization time-of-flight mass spectrometry (MALDI-TOF MS). Eur. J. Clin. Microbiol. Infect. Dis.38(10), 1795–1801 (2019).
   PubMed Web of Science ®Google Scholar
• HrabákJ , ChudáčkovaE , PapagiannitsisCC. Detection of carbapenemases in Enterobacteriaceae: a challenge for diagnostic microbiological laboratories. Clin. Microbiol. Infect.20(9), 839–853 (2014).
   PubMed Web of Science ®Google Scholar
• BernabeuS , PoirelL , NordmannP. Spectrophotometry-based detection of carbapenemase producers among Enterobacteriaceae. Diagn. Microbiol. Infect. Dis.74(1), 88–90 (2012).
   PubMed Web of Science ®Google Scholar
• KaaseM , SzabadosF , WassillL , GatermannSG. Detection of carbapenemases in Enterobacteriaceae by a commercial multiplex PCR. J. Clin. Microbiol.50(9), 3115–3118 (2012).
   PubMed Web of Science ®Google Scholar
• Garcia-FernandezS , MorosiniM-I , MarcoFet al.Evaluation of the eazyplex® SuperBug CRE system for rapid detection of carbapenemases and ESBLs in clinical Enterobacteriaceae isolates recovered at two Spanish hospitals. J. Antimicrob. Chemother.70, 1047–1050 (2014).
   PubMed Web of Science ®Google Scholar
• McEwanAS , DeromeA , MeunierD , BurnsPJ , WoodfordN , DodgsonAR. Evaluation of the NucliSENS EasyQ KPC assay for detection of Klebsiella pneumoniae Carbapenemase-Producing Enterobacteriaceae. J. Clin. Microbiol.51(6), 1948–1950 (2013).
   PubMed Web of Science ®Google Scholar
• NijhuisR , SamuelsenØ , SavelkoulP , van ZwetA. Evaluation of a new real-time PCR assay (Check-Direct CPE) for rapid detection of KPC, OXA-48, VIM, and NDM carbapenemases using spiked rectal swabs. Diagn. Microbiol. Infect. Dis.77(4), 316–320 (2013).
   PubMed Web of Science ®Google Scholar
• TraczewskiMM , CarrettoE , CantonRet al.Multicenter evaluation of the Xpert Carba-R Assay for detection of carbapenemase genes in Gram-negative isolates. J. Clin. Microbiol.56(8), e00272–18 (2018).
   PubMed Web of Science ®Google Scholar
• DoyleD , PeiranoG , LascolsC , LloydT , ChurchDL , PitoutJDD. Laboratory detection of Enterobacteriaceae that produce carbapenemases. J. Clin. Microbiol.50(12), 3877–3880 (2012).
   PubMed Web of Science ®Google Scholar
• WoodfordN , TiernoPM , YoungKet al.Outbreak of Klebsiella pneumoniae producing a new carbapenem- hydrolyzing class A -Lactamase, KPC-3, in a New York Medical Center. Antimicrob. Agents Chemother.48(12), 4793–4799 (2004).
   PubMed Web of Science ®Google Scholar
• PoirelL , WalshTR , CuvillierV , NordmannP. Multiplex PCR for detection of acquired carbapenemase genes. Diagn. Microbiol. Infect. Dis.70(1), 119–123 (2011).
   PubMed Web of Science ®Google Scholar
• SendaK , ArakawaY , IchiyamaSet al.PCR detection of metallo-β-lactamase gene (blaIMP) in Gram-negative rods resistant to broad-spectrum β-lactams. J. Clin. Microbiol.34(12), 2909–2913 (1996).
   PubMed Web of Science ®Google Scholar
• PoirelL , NaasT , NicolasDet al.Characterization of VIM-2, a carbapenem-hydrolyzing metallo-β-lactamase and its plasmid-and integron-borne gene from a Pseudomonas aeruginosa clinical isolate in France. Antimicrob. Agents Chemother.44(4), 891–897 (2000).
   PubMed Web of Science ®Google Scholar
• TsakrisA , PournarasS , WoodfordNet al.Outbreak of infections caused by Pseudomonas aeruginosa Producing VIM-1 carbapenemase in Greece. 38(3), 1290–1292 (2000).
   Google Scholar
• NordmannP , PoirelL , CarrerA , TolemanMA , WalshTR. How to detect NDM-1 producers. J. Clin. Microbiol.49(2), 718–721 (2011).
   PubMed Web of Science ®Google Scholar
• PeiranoG , Ahmed-BentleyJ , WoodfordN , PitoutJD. New Delhi metallo-β-lactamase from traveler returning to Canada. Emerg. Infect. Dis.17(2), 242–244 (2011).
   PubMed Web of Science ®Google Scholar
• PoirelL , BonninRA , NordmannP. Genetic features of the widespread plasmid coding for the carbapenemase OXA-48. Antimicrob. Agents Chemother.56(1), 559–562 (2012).
   PubMed Web of Science ®Google Scholar
• AktaşZ , BalKayacan Ç , SchneiderI , CanB , MidilliK , BauernfeindA. Carbapenem-hydrolyzing oxacillinase, OXA-48, persists in Klebsiella pneumoniae in Istanbul, Turkey. Chemotherapy54(2), 101–106 (2008).
   PubMed Web of Science ®Google Scholar
• MentastiM , PrimeK , SandsK , KhanS , WoottonM. Rapid detection of IMP, NDM, VIM, KPC and OXA-48-like carbapenemases from Enterobacteriales and Gram-negative non-fermenter bacteria by real-time PCR and melt-curve analysis. Eur. J. Clin. Microbiol. Infect. Dis.38(11), 2029–2036 (2019).
   PubMed Web of Science ®Google Scholar
• CunninghamSA , VasooS , PatelR. Evaluation of the check-points check MDR CT103 and CT103 XL microarray kits by use of preparatory rapid cell lysis. J. Clin. Microbiol.54(5), 1368–1371 (2016).
   PubMed Web of Science ®Google Scholar
• MurphyNM , McLauchlinJ , OhaiC , GrantKA. Construction and evaluation of a microbiological positive process internal control for PCR-based examination of food samples for Listeria monocytogenes and Salmonella enterica. Int. J. Food Microbiol.120(1–2), 110–119 (2007).
   PubMed Web of Science ®Google Scholar
• GuptaK , BhadeliaN. Management of urinary tract infections from multidrug-resistant organisms. Infect. Dis. Clin. North Am.28(1), 49–59 (2014).
   PubMed Web of Science ®Google Scholar
• AlizadehN , RezaeeMA , KafilHSet al.Detection of carbapenem-resistant Enterobacteriaceae by chromogenic screening media. J. Microbiol. Methods153, 40–44 (2018).
   PubMed Web of Science ®Google Scholar
• PeriAM , DoiY , PotoskiBA , HarrisPNA , PatersonDL , RighiE. Antimicrobial treatment challenges in the era of carbapenem resistance. Diagn. Microbiol. Infect. Dis.94(4), 413–425 (2019).
   PubMed Web of Science ®Google Scholar
• GiamarellouH , GalaniL , BaziakaF , KaraiskosI. Effectiveness of a double-carbapenem regimen for infections in humans due to carbapenemase-producing pandrug-resistant Klebsiella pneumoniae. Antimicrob. Agents Chemother.57(5), 2388–2390 (2013).
   PubMed Web of Science ®Google Scholar
• CeccarelliG , FalconeM , GiordanoAet al.Successful ertapenem–doripenem combination treatment of bacteremic ventilator-associated pneumonia due to colistin-resistant KPC-producing Klebsiella pneumoniae. Antimicrob. Agents Chemother.57(6), 2900–2901 (2013).
   PubMed Web of Science ®Google Scholar
• LagerbäckP , KhineWWT , GiskeCG , TängdénT. Evaluation of antibacterial activities of colistin, rifampicin and meropenem combinations against NDM-1-producing Klebsiella pneumoniae in 24 h in vitro time–kill experiments. J. Antimicrob. Chemother.71(8), 2321–2325 (2016).
   PubMed Web of Science ®Google Scholar
• SongJY , KeeSY , HwangISet al.In vitro activities of carbapenem/sulbactam combination, colistin, colistin/rifampicin combination and tigecycline against carbapenem-resistant Acinetobacter baumannii. J. Antimicrob. Chemother.60(2), 317–322 (2007).
   PubMed Web of Science ®Google Scholar
• DerisZZ , YuHH , DavisKet al.The combination of colistin and doripenem is synergistic against Klebsiella pneumoniae at multiple inocula and suppresses colistin resistance in an In Vitro Pharmacokinetic/Pharmacodynamic Model. Antimicrob. Agents Chemother.56(10), 5103–5112 (2012).
   PubMed Web of Science ®Google Scholar
• YadavR , LandersdorferCB , NationRL , BoyceJD , BulittaJB. Novel approach to optimize synergistic carbapenem-aminoglycoside combinations against carbapenem-resistant Acinetobacter baumannii. Antimicrob. Agents Chemother.59(4), 2286–2298 (2015).
   PubMed Web of Science ®Google Scholar
• PaulM , DaikosGL , Durante-MangoniEet al.Colistin alone versus colistin plus meropenem for treatment of severe infections caused by carbapenem-resistant Gram-negative bacteria: an open-label, randomised controlled trial. Lancet Infect. Dis.18(4), 391–400 (2018).
   PubMed Web of Science ®Google Scholar
• FalagasME , RafailidisPI , KasiakouSK , HatzopoulouP , MichalopoulosA. Effectiveness and nephrotoxicity of colistin monotherapy vs colistin–meropenem combination therapy for multidrug-resistant Gram-negative bacterial infections. Clin. Microbiol. Infect.12(12), 1227–1230 (2006).
   PubMed Web of Science ®Google Scholar
• Rodríguez-AvialI , PenaI , PicazoJJ , Rodríguez-AvialC , CulebrasE. In vitro activity of the next-generation aminoglycoside plazomicin alone and in combination with colistin, meropenem, fosfomycin or tigecycline against carbapenemase-producing Enterobacteriaceae strains. Int. J. Antimicrob. Agents46(6), 616–621 (2015).
   PubMed Web of Science ®Google Scholar
• ToussaintKA , GallagherJC. β-lactam/β-lactamase inhibitor combinations: from then to now. Ann. Pharmacother.49(1), 86–98 (2015).
   PubMed Web of Science ®Google Scholar
• GibsonB. A brief review of a new antibiotic: meropenem-vaborbactam. Sr. Care Pharm.34(3), 187–191 (2019).
   PubMedGoogle Scholar
• SmibertO , SatlinMJ , NelloreA , PelegAY. Carbapenem-resistant Enterobacteriaceae in solid organ transplantation: management principles. Curr. Infect. Dis. Rep.21(7), 26–37 (2019).
   PubMed Web of Science ®Google Scholar
• FalagasME , SkalidisT , VardakasKZ , LegakisNJ. on behalf of the Hellenic Cefiderocol Study Group. Activity of cefiderocol (S-649266) against carbapenem-resistant Gram-negative bacteria collected from inpatients in Greek hospitals. J. Antimicrob. Chemother.72(6), 1704–1708 (2017).
   PubMed Web of Science ®Google Scholar
• KohiraN , WestJ , ItoAet al.Invitro antimicrobial activity of a siderophore cephalosporin, S-649266, against Enterobacteriaceae clinical isolates, including carbapenem-resistant strains. Antimicrob. Agents Chemother.60(2), 729–734 (2016).
   PubMed Web of Science ®Google Scholar
• Ito-HoriyamaT , IshiiY , ItoAet al.Stability of novel siderophore cephalosporin S-649266 against clinically relevant carbapenemases. Antimicrob. Agents Chemother.60(7), 4384–4386 (2016).
   PubMed Web of Science ®Google Scholar
• BassettiM , RighiE. Eravacycline for the treatment of intra-abdominal infections. Expert Opin. Investig. Drugs23(11), 1575–1584 (2014).
   PubMed Web of Science ®Google Scholar
• FishmanN. Antimicrobial stewardship. Am. J. Infect. Control34(5), S55–S63 (2006).
   PubMed Web of Science ®Google Scholar
• FishmanN. Society for Healthcare Epidemiology of America, Infectious Diseases Society of America, Pediatric Infectious Diseases Society. Policy statement on antimicrobial stewardship by the Society for Healthcare Epidemiology of America (SHEA), the Infectious Diseases Society of America (IDSA), and the Pediatric Infectious Diseases Society (PIDS). Infect. Control Hosp. Epidemiol.33(4), 322–327 (2012).
   PubMed Web of Science ®Google Scholar
• DellitTH , OwensRC , McGowanJEet al.Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin. Infect. Dis.44(2), 159–177 (2007).
   PubMed Web of Science ®Google Scholar